vs
CLOVER HEALTH INVESTMENTS, CORP.（CLOV）与Mativ Holdings, Inc.（MATV）财务数据对比。点击上方公司名可切换其他公司
CLOVER HEALTH INVESTMENTS, CORP.的季度营收约是Mativ Holdings, Inc.的1.6倍（$749.2M vs $463.1M），Mativ Holdings, Inc.净利率更高（21.8% vs 3.6%，领先18.1%），CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（62.0% vs 1.0%），过去两年CLOVER HEALTH INVESTMENTS, CORP.的营收复合增速更高（45.0% vs -3.8%）
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
Mativ Holdings是一家全球特种材料制造商，主要生产高性能先进聚合物、无纺布、过滤解决方案及功能性涂层材料，服务医疗、工业、消费品、航空航天、能源等领域，业务遍及北美、欧洲及亚太地区。
CLOV vs MATV — 直观对比
营收规模更大
CLOV
是对方的1.6倍
$463.1M
营收增速更快
CLOV
高出61.1%
1.0%
净利率更高
MATV
高出18.1%
3.6%
两年增速更快
CLOV
近两年复合增速
-3.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $749.2M | $463.1M |
| 净利润 | $27.3M | $100.8M |
| 毛利率 | — | 18.8% |
| 营业利润率 | 3.6% | 2.2% |
| 净利率 | 3.6% | 21.8% |
| 营收同比 | 62.0% | 1.0% |
| 净利润同比 | — | 6620.0% |
| 每股收益（稀释后） | $0.05 | $1.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLOVMATV
| Q1 26 | $749.2M | — | ||
| Q4 25 | $487.7M | $463.1M | ||
| Q3 25 | $496.6M | $513.7M | ||
| Q2 25 | $477.6M | $525.4M | ||
| Q1 25 | $462.3M | $484.8M | ||
| Q4 24 | $337.0M | $458.6M | ||
| Q3 24 | $331.0M | $498.5M | ||
| Q2 24 | $356.3M | $523.8M |
净利润CLOVMATV
| Q1 26 | $27.3M | — | ||
| Q4 25 | $-49.3M | $100.8M | ||
| Q3 25 | $-24.4M | $-3.2M | ||
| Q2 25 | $-10.6M | $-9.5M | ||
| Q1 25 | $-1.3M | $-425.5M | ||
| Q4 24 | $-22.1M | $1.5M | ||
| Q3 24 | $-9.2M | $-20.8M | ||
| Q2 24 | $7.4M | $-1.4M |
毛利率CLOVMATV
| Q1 26 | — | — | ||
| Q4 25 | — | 18.8% | ||
| Q3 25 | — | 19.3% | ||
| Q2 25 | — | 19.7% | ||
| Q1 25 | — | 15.0% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | 24.5% | 18.8% | ||
| Q2 24 | 30.3% | 20.8% |
营业利润率CLOVMATV
| Q1 26 | 3.6% | — | ||
| Q4 25 | -10.1% | 2.2% | ||
| Q3 25 | -4.9% | 3.1% | ||
| Q2 25 | -2.2% | 3.8% | ||
| Q1 25 | -0.3% | -88.8% | ||
| Q4 24 | -6.4% | 0.6% | ||
| Q3 24 | -2.7% | 1.4% | ||
| Q2 24 | 2.0% | 2.0% |
净利率CLOVMATV
| Q1 26 | 3.6% | — | ||
| Q4 25 | -10.1% | 21.8% | ||
| Q3 25 | -4.9% | -0.6% | ||
| Q2 25 | -2.2% | -1.8% | ||
| Q1 25 | -0.3% | -87.8% | ||
| Q4 24 | -6.6% | 0.3% | ||
| Q3 24 | -2.8% | -4.2% | ||
| Q2 24 | 2.1% | -0.3% |
每股收益（稀释后）CLOVMATV
| Q1 26 | $0.05 | — | ||
| Q4 25 | — | $1.87 | ||
| Q3 25 | — | $-0.06 | ||
| Q2 25 | — | $-0.18 | ||
| Q1 25 | — | $-7.82 | ||
| Q4 24 | — | $0.03 | ||
| Q3 24 | — | $-0.38 | ||
| Q2 24 | — | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $177.6M | $84.2M |
| 总债务越低越好 | — | $1.0B |
| 股东权益账面价值 | $339.4M | $498.7M |
| 总资产 | $697.7M | $2.1B |
| 负债/权益比越低杠杆越低 | — | 2.07× |
8季度趋势，按日历期对齐
现金及短期投资CLOVMATV
| Q1 26 | $177.6M | — | ||
| Q4 25 | $78.3M | $84.2M | ||
| Q3 25 | — | $97.1M | ||
| Q2 25 | — | $95.6M | ||
| Q1 25 | — | $84.0M | ||
| Q4 24 | $194.5M | $94.3M | ||
| Q3 24 | $288.0M | $162.2M | ||
| Q2 24 | $254.8M | $133.4M |
总债务CLOVMATV
| Q1 26 | — | — | ||
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.2B |
股东权益CLOVMATV
| Q1 26 | $339.4M | — | ||
| Q4 25 | $308.7M | $498.7M | ||
| Q3 25 | $340.9M | $397.4M | ||
| Q2 25 | $344.2M | $416.6M | ||
| Q1 25 | $336.1M | $428.2M | ||
| Q4 24 | $341.1M | $858.5M | ||
| Q3 24 | $342.2M | $882.3M | ||
| Q2 24 | $324.9M | $898.0M |
总资产CLOVMATV
| Q1 26 | $697.7M | — | ||
| Q4 25 | $541.0M | $2.1B | ||
| Q3 25 | $559.7M | $2.0B | ||
| Q2 25 | $575.0M | $2.1B | ||
| Q1 25 | $583.7M | $2.1B | ||
| Q4 24 | $580.7M | $2.4B | ||
| Q3 24 | $653.0M | $2.6B | ||
| Q2 24 | $674.2M | $2.6B |
负债/权益比CLOVMATV
| Q1 26 | — | — | ||
| Q4 25 | — | 2.07× | ||
| Q3 25 | — | 2.63× | ||
| Q2 25 | — | 2.66× | ||
| Q1 25 | — | 2.67× | ||
| Q4 24 | — | 1.30× | ||
| Q3 24 | — | 1.32× | ||
| Q2 24 | — | 1.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $19.3M |
| 自由现金流经营现金流 - 资本支出 | — | $8.0M |
| 自由现金流率自由现金流/营收 | — | 1.7% |
| 资本支出强度资本支出/营收 | — | 2.4% |
| 现金转化率经营现金流/净利润 | — | 0.19× |
| 过去12个月自由现金流最近4个季度 | — | $93.8M |
8季度趋势，按日历期对齐
经营现金流CLOVMATV
| Q1 26 | — | — | ||
| Q4 25 | $-66.9M | $19.3M | ||
| Q3 25 | $12.1M | $72.8M | ||
| Q2 25 | $5.4M | $57.6M | ||
| Q1 25 | $-16.3M | $-15.9M | ||
| Q4 24 | $34.8M | $24.1M | ||
| Q3 24 | $50.0M | $37.6M | ||
| Q2 24 | $44.8M | $46.1M |
自由现金流CLOVMATV
| Q1 26 | — | — | ||
| Q4 25 | $-69.0M | $8.0M | ||
| Q3 25 | $11.4M | $66.7M | ||
| Q2 25 | $4.8M | $48.9M | ||
| Q1 25 | $-16.5M | $-29.8M | ||
| Q4 24 | $33.3M | $2.0M | ||
| Q3 24 | $49.6M | $25.5M | ||
| Q2 24 | $44.4M | $37.4M |
自由现金流率CLOVMATV
| Q1 26 | — | — | ||
| Q4 25 | -14.1% | 1.7% | ||
| Q3 25 | 2.3% | 13.0% | ||
| Q2 25 | 1.0% | 9.3% | ||
| Q1 25 | -3.6% | -6.1% | ||
| Q4 24 | 9.9% | 0.4% | ||
| Q3 24 | 15.0% | 5.1% | ||
| Q2 24 | 12.5% | 7.1% |
资本支出强度CLOVMATV
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 2.4% | ||
| Q3 25 | 0.1% | 1.2% | ||
| Q2 25 | 0.1% | 1.7% | ||
| Q1 25 | 0.0% | 2.9% | ||
| Q4 24 | 0.5% | 4.8% | ||
| Q3 24 | 0.1% | 2.4% | ||
| Q2 24 | 0.1% | 1.7% |
现金转化率CLOVMATV
| Q1 26 | — | — | ||
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 16.07× | ||
| Q3 24 | — | — | ||
| Q2 24 | 6.04× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLOV
暂无分部数据
MATV
| Other | $208.7M | 45% |
| SAS Segment | $157.4M | 34% |
| FAM Segment | $97.0M | 21% |
